Inventor
MEKONNEN BELEW
US13 patents
⚠️ This page may combine multiple inventors who share the name “MEKONNEN BELEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGENEBIO INC
9 patentsUS11142529B2Oct 12, 2021
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC6 citations82
US10815242B2Oct 27, 2020
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC7 citations82
US10329301B2Jun 25, 2019
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC6 citations82
US11505555B2Nov 22, 2022
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC2 citations71
US11312721B2Apr 26, 2022
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC2 citations71
US12291535B2May 6, 2025
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC2 citations70
US12024525B2Jul 2, 2024
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC0 citations61
US11414425B2Aug 16, 2022
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC0 citations58
US12528819B2Jan 20, 2026
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AGENEBIO INC0 citations50
HAGER BIOSCIENCES LLC
3 patentsUS12187737B2Jan 7, 2025
Imidazolo derivatives, compositions and methods as orexin antagonists
HAGER BIOSCIENCES LLC0 citations56
US12187738B2Jan 7, 2025
Imidazolo derivatives, compositions and methods as orexin antagonists
HAGER BIOSCIENCES LLC0 citations56
US12275744B2Apr 15, 2025
Pyrazole and imidazole derivatives, compositions and methods as orexin antagonists
HAGER BIOSCIENCES LLC0 citations45